bluebird bio Inc (BLUE) – Company Profile and SWOT Analysis
- Pages: 53
- Published: October 2024
- Report Code: MLPH137067FSA
bluebird bio Inc (BLUE) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
bluebird bio Inc (bluebird bio) is a biotechnology company that focuses on the development and commercialization of gene therapies for severe genetic diseases and cancer. The company develops its products based on integrated product platforms such as lentiviral gene addition platform, cancer immunotherapy and gene editing. Its product pipeline includes elivaldogene autotemcel for the treatment of cerebral adrenoleukodystrophy (CALD); betibeglogene autotemcel for transfusion-dependent beta thalassemia; Lovo-cel for the treatment of sickle cell disease, besides compounds under development for the treatment of various cancers. The company has collaboration with pharmaceutical companies to discover, develop and commercialize gene therapy products. bluebird bio is headquartered in Cambridge, Massachusetts, the US.
Scope
• Detailed information on bluebird bio Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting bluebird bio Inc in the form of a SWOT analysis
• An in-depth view of the business model of bluebird bio Inc including a breakdown and examination of key business segments
• News about bluebird bio Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of bluebird bio Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess bluebird bio Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on bluebird bio Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Global Blood Therapeutics Inc
Acceleron Pharma Inc
Intellia Therapeutics Inc
Chiesi USA Inc
Bellicum Pharmaceuticals Inc
Beam Therapeutics Inc
Sangamo Therapeutics Inc
Novartis AG
GlycoMimetics Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.